Zubair Muhammad, Akhtar Muhammad Anas Bin, Tayyab Zain, Kazim Sayed Moosa, Syed Aamir, Khattak Shahid, Tayyab Muhammad, Atiq Hafsa, Alauddin Muhammad, Afzaal Muhammad
Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PAK.
Cureus. 2024 Dec 1;16(12):e74916. doi: 10.7759/cureus.74916. eCollection 2024 Dec.
Background Signet ring cell carcinoma (SRCC) is a rare subtype of colorectal cancer with significant variations in clinical characteristics and poor prognosis. However, there is limited data available in Pakistan. Therefore, we analyzed to examine the incidence, clinicopathological features, treatments, and outcomes of SRCC in colorectal cancer cases in Pakistan. Methods This study includes 214 primary signet ring cell carcinoma cases in the colon and rectum. All relevant clinical information extracts on demographic details, laboratory results, radiological findings, endoscopy, pathologic diagnoses, surgical interventions, neoadjuvant and adjuvant therapies, and their corresponding outcomes were undertaken from the same online database of hospital and analyzed using SPSS (SPSS Inc., Chicago, IL, USA), Chi-square test, and independent sample Kruskal-Wallis H test. Results The prevalence of SRCC was higher in younger patients (<50 years), 184 (86%). SRCC was more common in advanced stages T3 and T4, with 210 (98%) cases and 106 cases (49.5%) belonging to stage N2. In 27 cases (12.6%), there was already distant metastasis. The most common site of recurrent disease in SRCC patients was the peritoneum in about 50 (51.5%) patients, followed by multi-site metastases involving the lung, liver, bones, and lymph nodes. Conclusion Signet ring cell colorectal cancer (SRCC) manifests in Pakistan at a younger age and is diagnosed at a more advanced stage, often accompanied by peritoneal metastasis with elevated levels of recurrence due to relatively low rates of screening and the absence of national cancer data and guidelines. It is imperative that these issues should be addressed in order to alleviate the burden of this disease in our population.
背景 印戒细胞癌(SRCC)是结直肠癌的一种罕见亚型,其临床特征差异显著,预后较差。然而,巴基斯坦的相关数据有限。因此,我们进行分析以研究巴基斯坦结直肠癌病例中印戒细胞癌的发病率、临床病理特征、治疗方法及预后。方法 本研究纳入了214例发生于结肠和直肠的原发性印戒细胞癌病例。从同一医院在线数据库提取了所有相关临床信息,包括人口统计学细节、实验室检查结果、影像学检查结果、内镜检查、病理诊断、手术干预、新辅助和辅助治疗及其相应预后,并使用SPSS(美国伊利诺伊州芝加哥市SPSS公司)、卡方检验和独立样本Kruskal-Wallis H检验进行分析。结果 印戒细胞癌在年轻患者(<50岁)中更为常见,有184例(86%)。印戒细胞癌在T3和T4晚期更为常见,有210例(98%),其中106例(49.5%)属于N2期。27例(12.6%)已发生远处转移。印戒细胞癌患者复发最常见的部位是腹膜,约50例(51.5%)患者如此,其次是肺、肝、骨和淋巴结的多部位转移。结论 在巴基斯坦,结直肠印戒细胞癌(SRCC)发病年龄较轻,确诊时分期较晚,常伴有腹膜转移,由于筛查率相对较低以及缺乏国家癌症数据和指南,复发率较高。必须解决这些问题,以减轻我国人群中这种疾病的负担。